We are live on ! Find out more
SMMT icon

Summit Therapeutics
SMMT

100 hedge funds and large institutions have $87.7M invested in Summit Therapeutics in 2023 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

137% more capital invested

Capital invested by funds: $37.1M → $87.7M (+$50.7M)

40% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 25

10% more funds holding

Funds holding: 91 → 100 (+9)

1.99% more ownership

Funds ownership: 3.02% → 5.01% (+2%)

0% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 24

15% less call options, than puts

Call options by funds: $312K | Put options by funds: $366K

Holders
100
Holders Change
+9
Holders Change %
+9.89%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
24
Reduced
24
Closed
25
Calls
$312K
Puts
$366K
Net Calls
-$54K
Net Calls Change
-$639K

Top Buyers

1
BlackRock
BlackRock
New York
+$12.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$8.46M
3
State Street
State Street
Massachusetts
+$3.89M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.9M
5
Northern Trust
Northern Trust
Illinois
+$1.76M

Top Sellers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.39M
2
Millennium Management
Millennium Management
New York
-$1.44M
3
AIC
AWM Investment Company
New York
-$1.4M
4
Jane Street
Jane Street
New York
-$718K
5
HF
HRT Financial
New York
-$696K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$22M +$12.6M +6,917,788 +375%
BBA
2
Baker Bros. Advisors
New York
$15.8M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$15.3M +$8.46M +4,635,361 +316%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$6.73M +$2.9M +1,590,328 +146%
State Street
5
State Street
Massachusetts
$5.66M +$3.89M +2,131,675 +1,743%
Northern Trust
6
Northern Trust
Illinois
$2.59M +$1.76M +963,409 +1,446%
SPIA
7
Steward Partners Investment Advisory
New York
$1.51M -$55.8K -30,570 -5%
Morgan Stanley
8
Morgan Stanley
New York
$1.49M -$324K -177,785 -23%
AA
9
ALPS Advisors
Colorado
$1.29M +$936K +512,834 New
N
10
Nuveen
North Carolina
$978K +$711K +389,747 New
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$952K -$2.39M -1,309,223 -78%
Goldman Sachs
12
Goldman Sachs
New York
$881K -$164K -89,887 -20%
SAM
13
Shell Asset Management
Netherlands
$810K +$589K +322,738 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$799K +$498K +272,892 +601%
Charles Schwab
15
Charles Schwab
California
$781K +$541K +296,489 +2,033%
Swiss National Bank
16
Swiss National Bank
Switzerland
$763K +$554K +303,800 New
CL
17
CSS LLC
Illinois
$669K -$467K -256,096 -49%
Group One Trading
18
Group One Trading
Illinois
$543K +$138K +75,787 +54%
Two Sigma Investments
19
Two Sigma Investments
New York
$457K -$609K -333,959 -65%
Osaic Holdings
20
Osaic Holdings
Arizona
$423K +$23.4K +12,809 +8%
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$405K +$294K +161,287 New
State of Wisconsin Investment Board
22
State of Wisconsin Investment Board
Wisconsin
$335K +$243K +133,332 New
RhumbLine Advisers
23
RhumbLine Advisers
Massachusetts
$319K +$232K +127,226 New
CS
24
Credit Suisse
Switzerland
$299K +$217K +119,078 New
Millennium Management
25
Millennium Management
New York
$293K -$1.44M -787,210 -87%
1
2 3 4 5

SMMT Hedge Fund Activity: Q2 2023 in Review

100 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Summit Therapeutics (SMMT) for Q2 2023, worth a combined $87.7M — up 137% from $37.1M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new SMMT positions and 25 closed out — a net gain of 10 holders — while 24 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $12.6M. The largest seller was Susquehanna International Group, cutting an estimated $2.39M.

  • 100 institutional investors held Summit Therapeutics (SMMT) as of Q2 2023, up from 91 in Q1 2023.
  • Funds reported $87.7M of Summit Therapeutics stock for Q2 2023, up 137% quarter-over-quarter.
  • 35 funds opened new Summit Therapeutics positions in Q2 2023 and 25 closed out, a net change of +10 holders.
  • The largest Summit Therapeutics buyer in Q2 2023 was BlackRock, an estimated $12.6M added.
  • The largest Summit Therapeutics seller in Q2 2023 was Susquehanna International Group, an estimated $2.39M sold.

Based on aggregated 13F filings for Q2 2023.